Literature DB >> 8140705

Experimental and clinical observations on massive suprachoroidal hemorrhage.

V Lakhanpal1.   

Abstract

We have been able to create a reproducible experimental model of nonexpulsive massive suprachoroidal hemorrhage in a rabbit eye. Massive suprachoroidal hemorrhage was demonstrated on echography and confirmed on histopathologic examination in all eyes. The natural course of the disease suggests that there is very little change in the size of the choroidal detachment in the first 7 days. Maximum liquefaction of the suprachoroidal hemorrhage clot was seen to occur between 7 and 14 days. However, increased retinal and ciliary body atrophy was also noted at 14 days. Therefore, the optimum time to drain massive suprachoroidal hemorrhage appears to be between 7 and 14 days. Immediate sclerotomy during the acute formation of massive suprachoroidal hemorrhage resulted in further increase in the suprachoroidal hemorrhage, with marked extension of the hemorrhage into the retina and vitreous. Therefore, in our opinion, immediate sclerotomy during massive suprachoroidal hemorrhage is detrimental to the eye. Our clinical data have shown that eyes with massive suprachoroidal hemorrhage can be treated successfully by secondary surgery, and the majority of the eyes can be salvaged with good visual results. No serious complications of this surgery were encountered in our cases. We advocate early surgical intervention between 7 and 14 days. Aggressive anterior and posterior segment reconstruction by anterior and posterior vitrectomy after sclerotomy drainage of the suprachoroidal hemorrhage is essential for better anatomic and visual results. Our animal data and clinical experience suggest that the optimum time of drainage of massive suprachoroidal hemorrhage is between 7 and 14 days. The results of our animal experiments in relation to human clinical application should be taken with caution. Furthermore, we had a small number of animals to study the various groups. In addition, longer follow-up may be needed for comparing controls with the treatment groups. Our animal model may help in such future studies on massive suprachoroidal hemorrhage.

Entities:  

Mesh:

Year:  1993        PMID: 8140705      PMCID: PMC1298482     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  70 in total

1.  Expulsive hemorrhage during retinal detachment surgery. A case with survival of the eye after Verhoeff sclerotomy.

Authors:  J R WOLTER
Journal:  Am J Ophthalmol       Date:  1961-02       Impact factor: 5.258

2.  Suprachoroidal hemorrhage after placement of a scleral-fixated lens.

Authors:  F W Price; W E Whitson
Journal:  J Cataract Refract Surg       Date:  1990-07       Impact factor: 3.351

3.  Choroidal detachment and retinal surgery.

Authors:  W R Hawkins; C L Schepens
Journal:  Am J Ophthalmol       Date:  1966-11       Impact factor: 5.258

4.  Spontaneous expulsive choroidal hemorrhage. A clinicopathologic report of two cases.

Authors:  D K Williams; P K Rentiers
Journal:  Arch Ophthalmol       Date:  1970-02

5.  Acute closed-angle glaucoma complicating hemorrhagic choroidal detachment associated with parenteral thrombolytic agents.

Authors:  T Steinemann; K Goins; T Smith; J Amrien; J Hollins
Journal:  Am J Ophthalmol       Date:  1988-12-15       Impact factor: 5.258

6.  Scleral trephination for subchoroidal effusion.

Authors:  A Dellaporta
Journal:  Arch Ophthalmol       Date:  1983-12

7.  The use of viscoelastic substances in the drainage of postoperative suprachoroidal hemorrhage.

Authors:  L B Baldwin; T J Smith; J L Hollins; P A Pearson
Journal:  Ophthalmic Surg       Date:  1989-07

8.  [On the clinical features of expulsive bleeding after cataract operations].

Authors:  G Holland
Journal:  Klin Monbl Augenheilkd       Date:  1966       Impact factor: 0.700

9.  Expulsive hemorrhage: a study of histopathological details.

Authors:  J R Wolter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

10.  Delayed nonexpulsive suprachoroidal hemorrhage.

Authors:  M G Gressel; R K Parrish; D K Heuer
Journal:  Arch Ophthalmol       Date:  1984-12
View more
  9 in total

1.  Retina to retina adhesions following suprachoroidal haemorrhage.

Authors:  D V Weinberg; L I Rosenberg
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

2.  Intraoperative complications during cataract surgery in the very old.

Authors:  D K Berler
Journal:  Trans Am Ophthalmol Soc       Date:  2000

3.  Minimally Invasive Technique for Choroidal Fluid Drainage.

Authors:  Shadi Safuri; Laura Bar-David; Yoreh Barak
Journal:  Clin Ophthalmol       Date:  2020-07-09

4.  Suprachoroidal haemorrhage complicating cataract surgery in the UK: epidemiology, clinical features, management, and outcomes.

Authors:  R Ling; M Cole; C James; S Kamalarajah; B Foot; S Shaw
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

5.  Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage.

Authors:  Nancy Kunjukunju; Christine R Gonzales; William S Rodden
Journal:  Clin Ophthalmol       Date:  2011-02-04

6.  Experimental Laboratory Modeling of Choroidal Vasculature: A Study of the Dynamics of Intraoperative Choroidal Hemorrhage during Pars Plana Vitrectomy

Authors:  Mahmut Doğramacı; Funda Dikkaya; Fevzi Şentürk; Cengiz Aras
Journal:  Turk J Ophthalmol       Date:  2021-10-26

7.  Commentary: The challenges of managing suprachoroidal hemorrhage.

Authors:  Pramod S Bhende; Shruthi Suresh
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

8.  Outcomes of suprachoroidal haemorrhage drainage with and without vitrectomy: a 10-year study.

Authors:  Amreen Qureshi; Assad Jalil; David C Sousa; Niall Patton; Felipe Dhawahir-Scala; Stephen J Charles; George Turner; Tsveta Ivanova
Journal:  Eye (Lond)       Date:  2020-09-02       Impact factor: 4.456

9.  Spontaneous suprachoroidal hemorrhage: Case report and review of the literature.

Authors:  Shu-Fang Hsiao; Min-Hsiu Shih; Fu-Chin Huang
Journal:  Taiwan J Ophthalmol       Date:  2015-01-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.